Clinical Trials Directory

Trials / Unknown

UnknownNCT00196157

Line Versus Spot Ablation in Persistent Atrial Fibrillation

Linear Anatomically Versus Focal Electrophysiologically Guided Substrate Ablation in Patients With Persistent Atrial Fibrillation

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
116 (estimated)
Sponsor
Deutsches Herzzentrum Muenchen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

In this randomized study dealing with the ablative treatment of persistent atrial fibrillation, two ablation strategies are compared: a more anatomically guided linear ablation scheme versus an electrophysiological guided focal ablation strategy aiming at the electrical isolating of the pulmonary veins and ablating areas of fragmented intracardiac electrograms thought to maintain atrial fibrillation.

Detailed description

This randomized study deals with two different ablative treatment strategies for persistent atrial fibrillation: a more anatomically guided linear ablation scheme with encircling of the ipsilateral pulmonary veins (PV), a left atrial roof line and an anterior line bridging the anterior mitral anulus to the ostium of the left superior PV versus an electrophysiological guided focal ablation strategy aiming at isolating, electrically, the PV and ablating areas of fragmented intracardiac electrograms thought to maintain atrial fibrillation. Both ablation approaches contain isolation of the most common source of triggering foci, i.e., the pulmonary veins and additional modification of the substrate maintaining atrial fibrillation. The study endpoint is a combined efficacy/safety analysis. Extensive follow-up with three-monthly 7 days holter ECG is provided.

Conditions

Interventions

TypeNameDescription
PROCEDURElinear anatomically oriented ablationslinear lesions to ablate persistent atrial fibrillation
PROCEDUREfocal electrophysiological oriented ablationsfocal electrophysiologically guided ablations to treat persistent atrial fibrillation

Timeline

Start date
2004-08-01
Primary completion
2008-05-01
Completion
2008-11-01
First posted
2005-09-20
Last updated
2009-05-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00196157. Inclusion in this directory is not an endorsement.